PROTAGENIC THERAPEUTICS INC (PTIX) Stock News

USA - Nasdaq - NASDAQ:PTIX - US74365N3017 - Common Stock

1.57 USD

-0.08 (-4.85%)

Last: 12/15/2025, 8:00:02 PM

1.57 USD

0 (0%)

Pre-Market: 12/16/2025, 5:24:43 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

PTIX Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: ACCESS Newswire

Results from Phase 1 Multiple-Dose Study of PT00114

a month ago - By: ACCESS Newswire

Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study

2 months ago - By: Benzinga - Mentions: CASI TLPH GLMD NDRA ...

12 Health Care Stocks Moving In Monday's After-Market Session

4 months ago - By: ACCESS Newswire

Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance

4 months ago - By: ACCESS Newswire

Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders

4 months ago - By: Benzinga - Mentions: AEMD CANF OM EVOK ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

7 months ago - By: Yahoo Finance - Mentions: LMT NVO DHI CMG

Protagenic & Phytanix Merge in All-Stock Move, Sparking Retail Frenzy

7 months ago - By: Halper Sadeh LLC - Mentions: INZY TXNM NYSE

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, TXNM, SVT, PTIX on Behalf of Shareholders

7 months ago - By: Brodsky & Smith LLC - Mentions: INZY TXNM NYSE

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq – PTIX)

7 months ago - By: ACCESS Newswire

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity

7 months ago - By: Stocktwits - Mentions: VXF NFLX JPM

Protagenic Therapeutics Merges With Phytanix Bio In All-Stock Deal: Retail Turns Extremely Bullish

7 months ago - By: Halper Sadeh LLC

PTIX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Protagenic Therapeutics, Inc. Is Fair to Shareholders